+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biosimilar"

Perfusion Bioreactors - Global Strategic Business Report - Product Thumbnail Image

Perfusion Bioreactors - Global Strategic Business Report

  • Report
  • November 2026
  • 377 Pages
  • Global
From
Plantibodies - Global Strategic Business Report - Product Thumbnail Image

Plantibodies - Global Strategic Business Report

  • Report
  • November 2026
  • 486 Pages
  • Global
From
From
Airlift Bioreactors - Global Strategic Business Report - Product Thumbnail Image

Airlift Bioreactors - Global Strategic Business Report

  • Report
  • November 2026
  • 553 Pages
  • Global
From
Digital Biomanufacturing - Global Strategic Business Report - Product Thumbnail Image

Digital Biomanufacturing - Global Strategic Business Report

  • Report
  • November 2026
  • 341 Pages
  • Global
From
Bioproduction - Global Strategic Business Report - Product Thumbnail Image

Bioproduction - Global Strategic Business Report

  • Report
  • November 2026
  • 380 Pages
  • Global
From
Biomanufacturing - Global Strategic Business Report - Product Thumbnail Image

Biomanufacturing - Global Strategic Business Report

  • Report
  • November 2026
  • 375 Pages
  • Global
From
Bio-Process Technology - Global Strategic Business Report - Product Thumbnail Image

Bio-Process Technology - Global Strategic Business Report

  • Report
  • November 2026
  • 383 Pages
  • Global
From
Serum-Free Media - Global Strategic Business Report 2026 - Product Thumbnail Image

Serum-Free Media - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 476 Pages
  • Global
From
From
From
Small-Scale Bioreactors - Global Strategic Business Report 2026 - Product Thumbnail Image

Small-Scale Bioreactors - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 141 Pages
  • Global
From
Cell Culture Media - Global Strategic Business Report - Product Thumbnail Image

Cell Culture Media - Global Strategic Business Report

  • Report
  • November 2026
  • 673 Pages
  • Global
From
Tissue Clearing - Global Strategic Business Report - Product Thumbnail Image

Tissue Clearing - Global Strategic Business Report

  • Report
  • November 2026
  • 467 Pages
  • Global
From
Microbial API - Global Strategic Business Report 2026 - Product Thumbnail Image

Microbial API - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 466 Pages
  • Global
From
Bioprocess Monitoring - Global Strategic Business Report - Product Thumbnail Image

Bioprocess Monitoring - Global Strategic Business Report

  • Report
  • November 2026
  • 676 Pages
  • Global
From
From
Continuous Bioprocessing - Global Strategic Business Report 2026 - Product Thumbnail Image

Continuous Bioprocessing - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 553 Pages
  • Global
From
Single Use Assemblies - Global Strategic Business Report 2026 - Product Thumbnail Image

Single Use Assemblies - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 390 Pages
  • Global
From
From
Loading Indicator

The Biosimilar market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs that are similar to existing biologic drugs. Biosimilars are created using a process called recombinant DNA technology, which involves the manipulation of genetic material to create a drug that is similar to an existing biologic drug. Biosimilars are typically used to treat chronic conditions such as cancer, rheumatoid arthritis, and multiple sclerosis. Biosimilars are typically cheaper than their brand-name counterparts, making them an attractive option for patients and healthcare providers. Some companies in the Biosimilar market include Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Mylan, Pfizer, Sandoz, and Teva Pharmaceuticals. Show Less Read more